Purdue Pharma pleads guilty, will pay billions for role in opioid epidemic

Purdue Pharma and the United States Department of Justice announced that they have reached a deal that resolves multiyear civil and criminal investigations into the pharmaceutical company’s marketing practices related to its opioid medications.The agreement is subject to the approval of the bankruptcy court, both sides said.According to DOJ and Purdue Pharma press releases, Purdue Pharma has agreed to plead guilty to three federal criminal charges. It will pay criminal fines of more than $3.5 billion, a criminal forfeiture of $2 billion and a civil settlement in the amount of $2.8Read More

Share on facebook
Share on twitter
Share on linkedin